Publication date: Jul 16, 2026
Vaccination is effective at preventing severe illness related to influenza, pneumococcal disease and coronavirus disease 2019 COVID-19. Vaccine coverage among older Australians is incomplete, and hospitals currently administer very few vaccine doses. This study investigated vaccination coverage for influenza, pneumococcal disease and COVID-19 among inpatients aged 65 years and over and patient-reported likelihood of accepting these vaccinations during hospitalisation. A patient survey and audit of the Australian Immunisation Register were performed on 2 days in 2023 at Prince of Wales Hospital in Sydney, Australia. All inpatients aged 65 years and over on the identified days (n = 506) were included in the audit. A total of 447 patients were offered surveys, with 311 (69. 6%) responses. The likelihood of accepting vaccinations was self-reported on a 5-point scale. Audit and survey data were not linked. Survey-reported vaccination coverage was 39. 2% for COVID-19 in the last 6 months, 68. 2% for influenza in 2023 and 32. 1% for pneumococcal vaccination ever. The proportion of patients ‘likely’ or ‘very likely’ to accept inpatient vaccination was 58. 2% for COVID-19, 62. 7% for influenza and 61. 1% for pneumococcus. The median likelihood score was higher among respondents who reported to be vaccinated than unvaccinated (4 vs. 3; P
| Concepts | Keywords |
|---|---|
| COVID‐19 | |
| influenza | |
| inpatient | |
| pneumococcal disease | |
| vaccination |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | influenza |
| disease | MESH | pneumococcal disease |
| disease | MESH | coronavirus disease 2019 |
| disease | MESH | included |